UBS Hires RBC Capital Biotech Bankers in US Health-Care Push

UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the US.

Noël Brown will become head of biotechnology at UBS, while Tim Chung and Alex Lim are both joining as managing directors, according to a memo reviewed by Bloomberg News. Brown and Chung will be based in New York. Lim will be based in San Francisco. A representative for UBS declined to comment.